The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia

Hu, 2015, Role of inflammation in benign prostatic hyperplasia development among Han Chinese: a population-based and single-institutional analysis, Int J Urol, 22, 1138, 10.1111/iju.12914 Garraway, 1991, High prevalence of benign prostatic hypertrophy in the community, Lancet, 338, 469, 10.1016/0140-6736(91)90543-X Nickel, 2006, The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis, Curr Opin Urol, 16, 5, 10.1097/01.mou.0000193365.46081.cd Roehrborn, 2002, Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia, Campbell's Urology, 1297 Nickel, 1994, Prostatic inflammation in benign prostatic hyperplasia—the third component?, Can J Urol, 1, 1 Di Silverio, 2003, Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis, Eur Urol, 43, 164, 10.1016/S0302-2838(02)00548-1 Nickel, 2001, Consensus development of a histopathological classification system for chronic prostatic inflammation, Br J Urol, 87, 797, 10.1046/j.1464-410x.2001.02193.x Sountoulides, 2010, Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction, World J Urol, 28, 3, 10.1007/s00345-009-0480-3 Gacci, 2013, Metabolic syndrome and lower urinary tract symptoms: the role of inflammation, Prostate Cancer Prostatic Dis, 16, 101, 10.1038/pcan.2012.44 Ribal, 2013, The link between benign prostatic hyperplasia and inflammation, Eur Urol Suppl, 12, 103, 10.1016/j.eursup.2013.08.001 Schaeffer, 2002, Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study, J Urol, 168, 1048, 10.1016/S0022-5347(05)64572-7 Sciarra, 2007, Inflammation and chronic prostatic diseases: evidence for a link?, Eur Urol, 52, 964, 10.1016/j.eururo.2007.06.038 Engelhardt, 2015, Tumor necrosis factor-α expression in patients with obstructive benign prostatic hyperplasia is associated with a higher incidence of asymptomatic inflammatory prostatitis NIH category IV and prostatic calcification, Scand J Urol, 1 Nickel, 2008, The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial, Eur Urol, 54, 1379, 10.1016/j.eururo.2007.11.026 Nickel, 1999, Asymptomatic inflammation and/or infection in benign prostatic hyperplasia, BJU Int, 84, 976, 10.1046/j.1464-410x.1999.00352.x Battikhi, 2006, Effects of chronic bacterial prostatitis on prostate specific antigen levels total and free in patients with benign prostatic hyperplasia and prostate cancer, Int Urol Nephrol, 38, 21, 10.1007/s11255-005-1662-6 Morote, 2000, Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen, Eur Urol, 37, 537, 10.1159/000020190 Okada, 2000, Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer, Urology, 55, 892, 10.1016/S0090-4295(00)00519-7 Simard, 2004, Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study, Urology, 64, 1098, 10.1016/j.urology.2004.08.060 Ozden, 2007, The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis, Int Urol Nephrol, 39, 859, 10.1007/s11255-006-9125-2